Trial Profile
Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Men and Women With Osteoporosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics
- 30 May 2023 Planned End Date changed from 1 Jan 2022 to 1 Jan 2026.
- 30 May 2023 Planned primary completion date changed from 1 Jan 2021 to 1 Jan 2025.
- 16 Apr 2019 Planned End Date changed from 1 Jan 2020 to 1 Jan 2022.